SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently trending as investors debate the massive valuation of its record-breaking IPO, with the community split between long-term bullish optimism for space infrastructure and bearish warnings regarding overvaluation and potential liquidity risks. While some retail traders are aggressively accumulating shares to hold for the future, others are actively scouting for entry points below IPO levels, waiting for the initial hype and volatility to settle.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is seeing high volatility and intense community speculation following a recent report that the company is exploring a potential sale to a major media entity. Investors are actively debating the viability of a buyout versus a standalone growth strategy, with many weighing the companys platform dominance and recent profitability against ongoing market skepticism and competitive pressures.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high volatility as capital rotates into the major SpaceX IPO, leading investors to debate whether this decline is a temporary liquidity shakeout or a broader sector de-rating. The community remains focused on upcoming launch catalysts and the stock's long-term competitive position versus Starlink, with many viewing the sharp price pullback as a potential buying opportunity.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as investors weigh potential antitrust hurdles, including reports of state-level lawsuits, against the company's efforts to finalize its major acquisition of Warner Bros. Discovery. While some community members remain focused on regulatory timelines and the strategic integration of content, others are actively debating the potential impact on share price and the long-term viability of the combined entity.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

The ERShares Private-Public Crossover ETF (XOVR) is trending as investors debate its structure and valuation in relation to its significant exposure to SpaceX. While some community members are frustrated by the fund's recent price stagnation despite SpaceX's growth, others view it as an accessible, liquid entry point for pre-IPO space exposure compared to more volatile alternatives.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is experiencing significant volatility and downward pressure as investors rotate out of the fund to pursue direct exposure to the upcoming SpaceX IPO, which has triggered widespread selling despite the fund's heavy concentration in high-growth private tech assets. The community remains deeply divided, with some investors aggressively adding to positions on the belief that current market prices trade at a steep discount to the fund's true net asset value, while others are frustrated by management's dilution through share offerings and a lack of communication regarding the fund's underlying valuation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong community interest as positive clinical data for its subcutaneous Briumvi treatment fuels expectations for a potential buyout. Investors are closely monitoring management's commentary and institutional positioning, with many hopeful that upcoming industry conferences will further validate the stock's long-term growth trajectory.

Tidal Trust II - Defiance Daily Target 2X Short ASTS ETF

ASTN is seeing significant volatility as traders leverage the ETF to play against the momentum of ASTS, which many investors view as a highly volatile meme stock. The community remains deeply divided, with bearish traders utilizing the 2X inverse ETF to bet on a correction while long-term bulls continue to debate the stock's valuation and potential for further gains.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors react to the launch of its midsize R2 SUV, sparking intense community debate over high lease pricing and the company's long-term profitability. While bullish traders point to strong demand and potential mass-market scaling, many are actively expressing frustration over recent stock volatility and the lack of aggressive production updates from leadership.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF is trending as investors react to the historic NYSE uplisting of Trulieve and broader sector anticipation surrounding upcoming DEA hearings. While the community is actively debating the impact of these regulatory catalysts and potential institutional inflow, ongoing price volatility remains a major talking point as traders navigate market manipulation concerns and shifting max pain levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bausch Health Companies Enters Oversold Territory (BHC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage in China

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage in China Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage in China PR Newswire LAVAL, QC, May 28, 2026 Thermage, a pioneer in non-invasive...

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

Bausch Health Announces 2026 Annual Meeting of Shareholder Results Bausch Health Announces 2026 Annual Meeting of Shareholder Results PR Newswire LAVAL, QC, May 19, 2026 LAVAL, QC, May 19, 2026...

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference PR Newswire LAVAL, QC, May 12, 2026...

Why Bausch Health Companies Was Crawling Higher This Week

Key PointsThere was notable growth on both the top and bottom lines...

Bausch Health Cos (NYSE:BHC) Sees Unusually-High Trading Volume  - Still a Buy?

Bausch Health Cos (NYSE:BHC) Sees Large Volume Increase - What's Next...

BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength

Bausch Health posts mixed Q1: EPS misses, but revenues beat estimates on strong Salix and Solta growth. Pipeline progress and the raised 2026 view add momentum.

Bausch Health Cos Q1 Earnings Call Highlights

Bausch Health Cos (NYSE:BHC) opened 2026 with what executives described as a strong performance, driven primarily by Salix and Solta Medical, while reaffirming full-year guidance for the company...

Bausch Health (BHC) Lags Q1 Earnings Estimates

Bausch (BHC) delivered earnings and revenue surprises of -3.11% and +4.72%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

BHCBausch Health Companies Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BHC News